Radiation Oncologist and Co-Director of the Genitourinary Program, Shalini Moningi, MD, joins the Cancer Advances podcast to discuss the latest advances in radiation therapy for prostate cancer. Listen as Dr. Moningi talks about SBRT, adaptive radiation, emerging biomarker data, and how these innovations are reshaping treatment selection, toxicity profiles, and patient's quality of life.

Breast density affects 50% of women and can significantly impact both cancer risk and early detection. Breast Radiologist, Paulette Turk, MD, and Medical Breast Program Director, Lakshmi Khatri, MD, join the Cancer Advances Podcast to discuss breast density, its risk implications and the role of supplemental screening. Listen as they explain how Cleveland Clinic is defining practical screening pathways in an area where national guidelines continue to evolve.

Shahzad Raza, MD, Hematologist at Cleveland Clinic, joins the Cancer Advances podcast to share insights from the RedirecTT-1 study. This study, presented at the 2025 American Society of Hematology (ASH) Annual Meeting, explores combining two bispecific antibodies, talquetamab and teclistamab, for patients with relapsed/refractory multiple myeloma with extramedullary disease. Listen as Dr. Raza discusses disease biology, outcomes, safety considerations and why this approach could be a major st...

Certified Oncology Social Worker Jane Dabney, MSW, LISW-S, OSW-C, joins the Cancer Advances Podcast to talk about the vital role social workers play in blood cancer care. Listen as she explains how social work helps identify barriers to transplant and cellular therapy, supports patient and caregiver preparedness, and strengthens continuity of care.

Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.

Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.

Allison Winter, MD, Hematology Oncologist and Medical Director for VeloSano, returns to the Cancer Advances podcast to discuss the latest advances in diagnosing and managing primary CNS lymphoma. Listen as Dr. Winter shares how evolving treatment strategies, including CAR T-cell therapy and novel clinical trials, are improving outcomes and helping preserve cognitive function.

Pregnancy-associated breast cancer is rare and complex, requiring careful coordination across specialties. Erin Roesch, MD, Breast Medical Oncologist, joins the Cancer Advances Podcast to discuss how a multidisciplinary team approach helps optimize treatment timing, ensures maternal and fetal safety, and supports patients through diagnosis, therapy, and recovery.

Radiation oncologist in the Burkhardt Brain Tumor and Neuro-Oncology Center and Associate Director of the Gamma Knife Center, Samuel Chao, MD, joins the Cancer Advances podcast to talk about how advances in Gamma Knife radiosurgery are transforming treatment for patients with brain metastases. Hear how innovations in imaging, staging, and safety are allowing clinicians to treat more lesions while preserving brain function.

Lauren Kopicky, DO, Breast Surgical Oncologist at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving management of the axilla in breast cancer care. Listen as Dr. Kopicky reviews key clinical trials, ongoing research, and how de-escalation strategies are shaping patient care, outcomes, and quality of life.

Radiation Oncologist and Co-Director of the Sarcoma Program, Shauna Campbell, DO, returns to the Cancer Advances Podcast, this time diving into something a bit different - how low dose radiation therapy could help with osteoarthritis. Listen as Dr. Campbell explains how radiation works as an anti-inflammatory treatment, the types of patients who may benefit most, and how it compares with common options like joint injections or surgery.

Theranostics is changing the way we approach cancer care by combining advanced imaging with targeted therapy. Elcin Zan, MD, Chair of the Department of Nuclear Medicine at Cleveland Clinic joins the Cancer Advances Podcast to discuss how theranostics is being used in prostate cancer, for neuroendocrine tumors and its potential use for other cancers.

Samuel Trosman, MD, a Head and Neck Surgeon at Cleveland Clinic Weston Hospital, joins the Cancer Advances Podcast to discuss personalized approaches to thyroid cancer surgery. Listen as Dr. Trosman shares evolving surgical strategies, risk assessment and the role of molecular testing in guiding care.

Emotional distress is common during cancer treatment, but research shows it may also impact treatment outcomes. Psychosocial Oncologist Shiyao Wang, MD, joins the Cancer Advances Podcast to discuss the STRESS-LUNG-1 trial and how addressing emotional distress can potentially influence treatment response.

Jame Abraham, MD, Chair of the Department of Hematology & Medical Oncology at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to discuss how artificial intelligence (AI) is transforming oncology care. Listen has he shares insights from Cleveland Clinic’s recent AI in healthcare conference, real-world applications such as clinical documentation and trial matching, and how AI may reshape research, patient care, and the future of cancer treatment.

Orthopedic Oncologist at Cleveland Clinic in Florida, Jorge Manrique-Succar, MD, returns to the Cancer Advances Podcast to share the latest advances in treating metastatic bone disease. Listen as Dr. Manrique talks about early intervention, advanced surgical techniques, and multidisciplinary collaboration are improving outcomes for cancer patients with skeletal-related complications.

Wen Wee Ma, MBBS, Enterprise Vice Chair for Research and Director of the Novel Cancer Therapeutics Center, joins the Cancer Advances Podcast to discuss a phase 1 trial of KB707 presented at ASCO 2025. This innovative therapy delivers IL-2 and IL-12 directly to the lungs through inhalation, aiming to minimize side effects and improve outcomes for patients with lung tumors. Dr. Ma shares early trial results and what they could mean for the future of cancer treatment.

Kelley Kozma, DO, MS, Medical Director for Oncology at Cleveland Clinic Martin Health in Florida, to discuss how targeted therapies, next generation sequencing, and personalized medicine are transforming breast cancer care. Listen as Dr. Kozma shares how innovations like HER2-low targeting, liquid biopsy, and circulating tumor DNA are helping clinicians tailor treatments and improve outcomes.

Brian Burkey, MD, MEd, Interim Director of the Scully Walsh Cancer Center and Division Chair of Otolaryngology Head and Neck Surgery at Cleveland Clinic in Florida, joins the Cancer Advances Podcast to talk about management strategies for clinically node-negative salivary gland cancer. Listen as Dr. Burkey highlights findings from an outcomes study and share strategies to better identify high-risk patients who may benefit from more aggressive treatment.

George Stark, PhD, and Christine McDonald, PhD, from Cleveland Clinic’s Lerner Research Institute, join the Cancer Advances Podcast to discuss the development of PALA as a novel immunostimulatory agent in oncology. Listen as they highlight promising preclinical data across multiple tumor types, potential for combination therapies and plans for clinical translation, including topical use for skin cancer.